AC
DVAX

Apex Capital’s Dynavax Technologies DVAX Stock Holding History

Apex Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$8.21M Sell
340,000
-40,000
-11% -$1M 0.88% 35
2015
Q3 		$9.32M Buy
380,000
+160,000
+73% +$4.53M 0.89% 38
2015
Q2 		$5.15M Buy
+220,000
New +$4.79M 0.45% 47

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Apex Capital's DVAX Position: Q4 2015 in Review

Apex Capital reduced its Dynavax Technologies (DVAX) stake by 11% in Q4 2015, selling an estimated $1M and leaving 340,000 shares worth $8.21M. The position accounts for 0.88% of the portfolio, ranked #35.

Apex Capital first reported a position in DVAX in Q2 2015 and has held it in 3 quarters since. The position peaked at $9.32M in Q3 2015. 152 funds tracked by Wall St. Rank hold DVAX as of Q4 2015.

  • Apex Capital held 340,000 shares of Dynavax Technologies worth $8.21M as of Q4 2015.
  • Apex Capital sold 40,000 Dynavax Technologies shares in Q4 2015, an estimated $1M.
  • Dynavax Technologies made up 0.88% of Apex Capital's portfolio in Q4 2015, its #35 holding.
  • Apex Capital first reported a position in Dynavax Technologies in Q2 2015 and has held it in 3 quarters since.
  • Apex Capital's Dynavax Technologies position peaked at $9.32M in Q3 2015.
  • 152 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2015.

Based on Apex Capital's 13F filing for Q4 2015, filed 16 Feb 2016.